Question follow-through · 41685
Innovative Medicines Fund
To ask the Secretary of State for Health and Social Care, what proportion of the ringfenced £340 million budget for the Innovative Medicines Fund has been spent in each year since its launch in June 2022.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 26 Mar 2025
- Target answer date
- 31 Mar 2025
- Answer
- 9 Apr 2025 · 14 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Economy and business
- Pharmacy: Finance · 27 Mar 2025
- Pharmacy · 17 Apr 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Draft Code of Practice on Electronic and Workplace Ballots for Statutory Trade Union Ballots · 15 Jul 2026
- Draft Trade Unions (Permissible Means of Voting) and Employment Rights (Unfair Dismissal) (Amendment) Order 2026 · 15 Jul 2026
- Taxation (Energy and Vehicles) Bill Committee: New Clause 5 · 1 Jul 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
26 Mar 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what proportion of the ringfenced £340 million budget for the Innovative Medicines Fund has been spent in each year since its launch in June 2022.
31 Mar 2025
Target answer date
Date supplied by the official written-questions record.
9 Apr 2025
Answer published
The Innovative Medicines Fund (IMF) was established to provide a funding mechanism for promising non-cancer medicines recommended by the National Institute for Health and Care Excellence (NICE) for a period of managed access to address uncertainties in th...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Pharmacy: Finance
27 Mar 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has plans to link pharmacy funding to inflation and National Living Wage increases.
Pharmacy: Finance
27 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will made an assessment of the potential merits of increasing the length of funding periods of pharmacies.
NHS England
31 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of closing NHS England on the (a) timeline for the production of the NHS 10-year plan and (b) publication date of that plan.
NHS: Databases
31 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will consider the final costs and benefits statement for programmes delivered under the National Programme of Technology, published on 6 June 2013, in his plans for (a) an NHS Federated Data
Dementia: Research
1 Apr 2025 · To ask the Secretary of State for Health and Social Care, how much funding was allocated to dementia research by (a) the National Institute for Health and Care Research, (b) UK Research and Innovation and (c) other public bodies in each of the last five y
Dementia: Clinical Trials
1 Apr 2025 · To ask the Secretary of State for Health and Social Care, how many phase (a) one, (b) two and (c) three dementia clinical trials there have been in the UK in each of the last ten years; and how many participants were recruited for each of those trials.
Pharmacy
17 Apr 2025 · To ask the Secretary of State for Health and Social Care, when he plans to publish the report on economic review into community pharmacy.
Spinal Muscular Atrophy: Babies
24 Apr 2025 · To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the UK National Screening Committee on timelines for implementing in-service evaluation of newborn screening for spinal muscular atrophy.
Spinal Muscular Atrophy: Babies
24 Apr 2025 · To ask the Secretary of State for Health and Social Care, what information the UK National Screening Committee has provided on the (a) format, (b) scale and (c) duration of the upcoming in-service evaluation of newborn screening for Spinal Muscular Atroph
Spinal Muscular Atrophy: Babies
24 Apr 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of launching newborn screening for Spinal Muscular Atrophy alongside the upcoming launch of newborn screening for severe combined immunodeficienc
Hormone Replacement Therapy
7 May 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2025 to Question 35541 on Hormone Replacement Therapy, what discussions he has had with the Medicines and Healthcare products Regulatory Agency on the adequacy of
Hormone Replacement Therapy
7 May 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 March 2025 to Question 35541 on Hormone Replacement Therapy, what discussions he has had with the Medicines and Healthcare products Regulatory Agency on the adequacy of